The vaccinia virus DNA-dependent RNA polymerase subunit gene rpol9 was identified, and its expression was examined at RNA and protein levels. Antibody to the multisubunit RNA polymerase purified from virions reacted with a polypeptide with an apparent Mr of 21,000 that was synthesized in reticulocyte lysates programmed with (i) mRNA Immunoblotting and metabolic labeling of infected cell proteins indicated that synthesis of the Mr-21,000 polypeptide started early and continued throughout virus infection, whereas the Mr-22,000 form appeared late following DNA replication. RNA analyses suggested that the rpol9 mRNA was expressed from a dual early/late promoter and that the protein-coding region of the mRNA was directly preceded by a short 5' poly(A) leader, apparently initiated within the TAAATG motif at the beginning of the open reading frame.
,996-Da protein with an acidic N terminus, reacted with Mr-21,000 and -22,000 polypeptides that cosedimented with purified RNA polymerase. Internal sequencing of the two polypeptides confirmed that both were encoded by A6R, and the gene was named rpol9 to indicate the predicted molecular mass of the polypeptide in kilodaltons.
Immunoblotting and metabolic labeling of infected cell proteins indicated that synthesis of the Mr-21,000 polypeptide started early and continued throughout virus infection, whereas the Mr-22,000 form appeared late following DNA replication. RNA analyses suggested that the rpol9 mRNA was expressed from a dual early/late promoter and that the protein-coding region of the mRNA was directly preceded by a short 5' poly(A) leader, apparently initiated within the TAAATG motif at the beginning of the open reading frame.
The encoding and virion packaging of a multisubunit DNA-dependent RNA polymerase are distinguishing features of vaccinia virus and other members of the Poxviridae that are in part responsible for the unique ability of these viruses to propagate within the cytoplasm of host cells (reviewed in references 27 and 28) . Genes for 6 of the 8 to 10 subunits of the RNA polymerase have been identified and named rpo147, rpo132, rpo35, rpo30, rpo22, and rpol8 according to the sizes of their predicted translation products in kilodaltons (2, 3, 5, 6, 11, 12, 31, 33) . The two large subunit genes rpo147 and rpo132 are homologous to the corresponding-size subunit genes of prokaryotic and eukaryotic RNA polymerases (6, 11, 31) . In addition, the sequence of the gene for one of the small subunits, rpo30, has significant similarities to that of the eukaryotic transcription elongation factor SIT (2) . By contrast, no homologs of the vaccinia virus RNA polymerase subunits encoded by rpo35, rpo22, and rpol8 have been identified.
Knowledge of the complete subunit structure of the vaccinia virus RNA polymerase is required for genetic and functional studies and to determine whether modified forms of the enzyme regulate early, intermediate, and late gene expression. As a further step toward this goal, we describe the identification and expression of rpo19, a viral gene encoding another small subunit of the vaccinia virus RNA polymerase.
MATERIALS AND METHODS
Cells and virus. Vaccinia virus (strain WR) was propagated in HeLa S3 cells suspended in a minimum essential spinner medium supplemented with 5% horse serum (Quality Bio-logicals Inc.). Virions were purified by two successive sucrose gradient sedimentations as described previously (23) . For in vivo labeling experiments, HeLa cell monolayers were grown in a minimum essential medium with 10% fetal calf serum.
Purification of RNA polymerase and protein sequencing. Vaccinia virus RNA polymerase was extracted from purified virions with deoxycholate (7, 13) and purified by chromatography on successive columns of DEAE-cellulose (DE52; Whatman), heparin agarose (BRL-Life Technologies, Inc.), single-stranded DNA agarose (BRL-Life Technologies), and phosphocellulose (Pll; Whatman) and by glycerol gradient sedimentation. The enzyme activity was assayed by using a bacteriophage M13mpl8 single-stranded DNA template as described previously (13) . Approximately 100 ,ug of pure enzyme was obtained from 5 x 1013 virion particles.
The RNA polymerase used for protein sequencing was purified alternatively on columns of DEAE-cellulose, phosphocellulose, and Bio-Gel A1.5m (Bio-Rad). Approximately 100 pug of the purified enzyme was denatured by sodium dodecyl sulfate (SDS) and applied to a preparative 5 to 15% linear gradient polyacrylamide gel; the resolved subunit proteins were electrophoretically transferred to a nitrocellulose membrane (Schleicher & Schuell). Proteins were stained with 0.1% ponceau S (Sigma), and membrane strips containing appropriate bands were sent to William Lane at the Harvard Microchemistry Laboratory, where they were treated in situ with trypsin. The resultant peptides were separated by high-pressure liquid chromatography (HPLC) on a C18 column, and some were then analyzed on a gas-phase protein sequencer (ABI model 470A) connected to a 120A on-line phenylthiohydantoin-amino acid analyzer as described previously (1) .
RNA hybridization and cell-free translation. Total cytoplasmic RNA was extracted from vaccinia virus-infected HeLa S3 cells and purified by CsCl centrifugation as described previously (14) . Approximately 100 ,ug of RNA, prepared at 4 h after infection of cells in the presence of cycloheximide (100 jig/ml), was hybridized to 1-cm2 pieces of nitrocellulose filter (BA85; Schleicher & Schuell) to which 20 to 25 p.g of cloned denatured plasmid DNA was immobilized. Filters were washed stringently, and the bound RNA was eluted as described previously (24) . In some experiments, RNA was synthesized in vitro from target DNA cloned in the Bluescript vector (Stratagene), using T7 RNA polymerase and the cap dinucleotide m7G(5')ppp(5')G (29) . Hybrid (32) .
DNA containing specific open reading frames (ORFs) was cloned by polymerase chain reaction (PCR; Perkin ElmerCetus) of pHAKpnl, using pairs of synthetic oligonucleotide primers. Amplified DNA was inserted either into the Bluescript vector for in vitro translation studies or into the pET3c vector for expression of the protein in Escherichia coli (see below).
E. coli expression and antiserum preparation. The fulllength A6R protein-coding sequence was amplified by PCR and cloned into the bacteriophage T7 expression vector pET3c (36 40 ,lI of protein A agarose beads for an additional 1 h. The beads were washed three times with buffer containing 50 mM Tris-HCl (pH 8), 300 mM NaCl, and 0.1% Triton X-100 and once with the latter buffer containing 0.1% SDS and 0.1% deoxycholate. The washed beads were boiled in the gel loading buffer, and the labeled proteins were analyzed by SDS-PAGE.
RNA analyses. Northern (RNA) blot (37) , nuclease Si digestion (3), and primer extension (4) techniques were used to characterize the rpol9 mRNA as described previously. poly(dT)-containing probe, used to characterize the 5' poly(A) leader, was prepared by two sequential PCRs as described previously (3) .
The probe for the 3'-end mapping by nuclease S1 digestion was prepared by filling in the 3'-recessed end generated by SpeI digestion (at nucleotide 4357) of pHABam 5 with the Klenow form of DNA polymerase and [a-32P]dCTP, followed by BglII digestion (at nucleotide 6110). Labeled probes were purified by electrophoresis on a 7 M urea-4% polyacrylamide gel before use.
Nucleotide sequence accession number. The 3,150-bp sequence from the HindIII A genomic fragment ( Fig. 2 ) has been entered into GenBank under accession number M76473.
RESULTS
Localization of an RNA polymerase subunit gene encoding an Mr-21,000 polypeptide. It was previously demonstrated that mRNA obtained from vaccinia virus-infected cells directed a cell-free translation system to produce 8 to 10 polypeptides that reacted with antibody raised to the RNA polymerase purified from vaccinia virions (25) . The approximate locations of the RNA polymerase genes were determined by selecting the mRNA by hybridization to cloned DNA fragments prior to translation in the micrococcal nuclease-treated reticulocyte system and immunoprecipitation. In this manner, evidence was obtained that several polypeptides estimated by SDS-PAGE to range from 130 to 17 kDa were encoded within the 42-kbp HindIIl A genomic segment which had been cloned in a cosmid vector (25) . Further analyses led to the precise localization of the genes encoding 132-kDa (6) and 35-kDa (5) subunits within the HindIII A fragment. In the present study, mapping of the gene encoding an Mr-21,000 RNA polymerase subunit was carried out.
As shown in Nucleotide sequencing and fine mapping. To identify the RNA polymerase gene, we needed the nucleotide sequence of the vaccinia virus DNA present in pHABam 4 and 5, of which only part had been reported at the time (34, 41) . We therefore determined about 800 bp of sequence (proximal to the BamHI site at nucleotide 4138) of pHABam 4 and the contiguous 2,300-bp sequence of pHABam 5 ( Fig. 2) . Examination of the nucleotide sequence revealed three complete ORFs, designated A5L, A6R, and A7L, respectively. These three ORFs are flanked by two ORFs identified previously: A4L, encoding a major structural protein P4b (34) , and A8L, encoding a subunit of the vaccinia virus early transcription factor (18) . Predicted molecular masses of the three proteins are 31 kDa for A5L, 19 kDa for A6R, and 43 kDa for A7L. None of the ORFs showed any significant amino acid sequence homology with entries in the National Biomedical Research Foundation protein data base (release 23) when analyzed by the FASTA program.
To further localize the RNA polymerase gene, we isolated viral RNA that hybridized to the BamHI-XbaI DNA fragment (nucleotides 4138 to 4710; Fig. 2 ) derived from the pHABam 5 and demonstrated that it directed the synthesis of an Mr-21,000 polypeptide that was immunoprecipitated with the antiserum raised to the RNA polymerase (data not shown). This result narrowed the candidate genes to A5L and A6R. Because of its size, we considered ORF A6R to be a good candidate for the gene encoding an RNA polymerase subunit that was estimated to be 21 kDa by SDS-PAGE. However, the protein encoded by ORF A5L might have VOL. 66, 1992 on December 22, 2017 by guest
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on December 22, 2017 by guest migrated anomalously fast because of its unusual amino acid content (11% proline and 13% threonine, compared with the average values of 5 and 6%, respectively, for protein sequences in GenBank). In addition, ORF A5L spans the BamHI site (Fig. 2) , consistent with the selection of some mRNA encoding the M,-21,000 polypeptide by hybridization to pHABam 4 as well to pHABam 5 ( Fig. 1) . To resolve these alternative possibilities, the DNAs for ORFs A5L and A6R were individually PCR amplified and cloned into a bacteriophage T7 expression vector (Bluescript), and the genes were transcribed in vitro with T7 RNA polymerase. The in vitro-synthesized RNAs were then translated in reticulocyte lysates in the presence of [35S]methionine, and the labeled proteins were subsequently immunoprecipitated with RNA polymerase antibody. A truncated bacterial lacZ gene template served as a control for the specificity of translation and antibody binding. Translation of the RNA made from the A6R template produced an Mr-21,000 polypeptide which reacted with antiserum to the viral RNA polymerase but not with the preimmune serum (Fig. 3) , whereas the A5L RNA produced an Mr-35,000 polypeptide that did not react with polymerase antiserum. Thus, these data were consistent with the encoding of the RNA polymerase subunit by the A6R ORF.
Subsequent to our determination of the sequence (Fig. 2 ) for the WR strain of vaccinia virus, the genomic sequence of the Copenhagen strain of vaccinia virus was reported (19 antiserum for an immunoblot analysis of fractions from a glycerol density gradient sedimentation of chromatographically purified vaccinia virus RNA polymerase. The autoradiograph indicated that the antiserum reacted with polypeptides of Mr 21,000 and 22,000 (Fig. 4B) that cosedimented with the peak of the RNA polymerase activity (Fig. 4A) . Individual fractions, however, showed differences in the ratios of the two polypeptides suggesting heterogeneity in the subunit composition of RNA polymerase molecules. Polypeptides of Mr 21,000 and 22,000 were also seen along with several other subunit proteins on a replica immunoblot probed with antibody to the whole RNA polymerase (Fig.  4C) as well as on a silver-stained SDS-polyacrylamide gel of purified RNA polymerase (Fig. 4D) . Analysis of glycerol gradient fractions of total soluble virion extracts prior to chromatographic purification, with the A6R-specific and the whole RNA polymerase antibodies, indicated that all of the packaged Mr-21,000 and -22,000 polypeptides were associated with the RNA polymerase (data not shown).
Protein sequence analysis. Since the M,-21,000 and Mr, 22 ,000 polypeptides associated with purified RNA polymerase reacted with antiserum that was raised to a gel-purified protein expressed from a cloned ORF, it seemed likely that they were products of the same gene. A less likely possibility, however, was that one of the two polypeptides crossreacted with the antiserum to the A6R protein. Therefore, we wanted to confirm the identities of the two proteins by peptide sequencing. Purified RNA polymerase was resolved by electrophoresis on a preparative 5 to 15% linear gradient polyacrylamide-SDS gel, and the resolved subunit proteins were transferred to a nitrocellulose membrane. After staining, strips containing the Mr-21,000 and Mr-22,000 bands were cut out. Proteins on the strips were digested in situ with trypsin, and the resultant peptides were separated by microbore reverse-phase HPLC on a C18 column. Very similar chromatographic patterns were obtained from the two proteins, and most of their major tryptic peptides were eluted from the column at identical times (Fig. 5) In an attempt to understand the size difference between the two proteins, we chose for microsequencing two additional tryptic peptides (peak e from the Mr-22,000 protein and peak f from the Mr-21,000 protein) because they seemed somewhat anomalous in either their retention times or relative abundance. Sequences HIGNHISALK (peak e) and IVES ASTHIEDAHSNLK (peak f) were obtained, results again consistent with the rpol9 sequence yet providing no information on possible modification of the proteins.
In vivo synthesis of the RNA polymerase subunit. To investigate the in vivo synthesis of the rpol9 subunit, proteins were extracted from infected cells at different time after virus inoculation and analyzed by immunoblotting with the anti-A6R serum (Fig. 6A) . The Mr-21,000 polypeptide was detected at 4 h after infection and increased in amount up to 24 h. By contrast, the Mr-22,000 polypeptide was prominent only late in infection and even at those times was less abundant than the more rapidly migrating one. An additional M,-35,000 polypeptide was detected at late times. infection and the Mr-22,000 polypeptide was not detected at all. These results suggested that the more rapidly migrating polypeptide was synthesized early and continued to be made throughout the infection, whereas the more slowly migrating one formed at late times. Nearly equal amounts of the two proteins were present in mature virions (Fig. 6A , lane V; see also Fig. 4B, C, and D) , suggesting either that some modification is coupled with virus packaging or that RNA polymerase containing the Mr-22,000 polypeptide is preferentially packaged.
To further investigate the time of synthesis of the two polypeptides, infected cells were pulse-labeled for 30 min with [35S]methionine at various times after infection and the labeled proteins were immunoprecipitated with anti-A6R serum. An autoradiogram of the SDS-PAGE confirmed that the M,-21,000 polypeptide was synthesized at 4 h postinfection and continued to be made thereafter, with the highest rate of synthesis at 12 h (Fig. 6B) . Although in far less amount, a protein of the same size was synthesized at 8 and 24 h after infection in the presence of araC. These results are consistent with early/late expression of the rpol9 gene product as shown by the immunoblot analysis. Very little labeled Mr-22,000 polypeptide was formed during a 30-min pulse even at late times, again suggesting that its formation involves some type of posttranslational modification. The coprecipitation of the two large RNA polymerase subunits (147 and 132 kDa) and some smaller ones with the rpol9 gene product suggested that significant assembly of RNA polymerase occurred during the 30-min pulse-labeling period.
Analysis of rpol9 mRNA by Northern blotting. To further investigate the expression of the rpol9 gene, we used
Northern blot analysis to determine the size and the steadystate level of the rpol9 mRNA during various stages of infection. Total infected-cell RNA was prepared and separated on a formaldehyde-agarose gel and transferred to a nitrocellulose membrane. A specific probe composed of the complemetary strand of the protein-coding region was prepared by oligonucleotide-primed asymmetric PCR and used for hybridization. A discrete-size mRNA was detected between 2 and 6 h after infection (Fig. 7A) . The size of the mRNA was about 750 bases, which was consistent with an ORF encoding a protein with a predicted molecular weight of 19,000. The steady-state level of this mRNA decreased abruptly after 6 h. An mRNA of the same size was present in cells infected with the inhibitor araC or cycloheximide, consistent with expression of rpol9 early in infection. As commonly noted for other early mRNAs, cycloheximide greatly increased the amount of the message.
Neither the 750-nucleotide band or another of discrete size was detected by Northern blot analysis using RNA obtained later than 6 h after infection. From 4 h on, however, an RNA smear ranging up to 4 kb in size was noted. The absence of the smear with uninfected-cell RNA or with infected-cell RNA made early or in the presence of araC or cycloheximide suggests that the probe did hybridize to specific late RNAs containing at least part of the rpol9 coding region. Translation of these heterogeneous RNAs late in infection would account for the continuous synthesis of the rpol9 protein described above. Northern blot smears have been found for other late mRNAs and are believed to result mainly from heterogenous sites of transcriptional termination.
Analysis of the 5' end of rpol9 mRNA. The 5' end of the rpol9 transcript was determined by two methods: nuclease S1 analysis and primer extension. For nuclease Si analysis, a single-stranded DNA probe complementary to the sequence from -713 to + 180 (+ 1 at the ATG start codon) was end labeled at nucleotide +180. A major band of protected probe, approximately 180 bases in length, was obtained with RNA isolated in the presence of cycloheximide and araC (Fig. 7B) . In the absence of drugs, the band was predominant with RNA harvested at 2, 4, and 6 h after infection but was detectable at all later time points as well. Two additional faint bands of 660 and 220 bases were also seen with late RNA; these will be discussed below. The size of the 180-base protected probe corresponds to a transcript with a 5' end at or a few bases upstream of the translation initiation codon of the A6R ORF within the sequence TAAATG (Fig.  2) . In this regard, we noted that the sequence AAAAT TGAATTGCGA, located 12 to 27 bases upstream of the J. VIROL. (8, 16, 20) , consistent with the continued synthesis of RNA starting at this site.
The faint 660-base band, detected by nuclease Si analysis only with RNA isolated at late times (Fig. 7B) , corresponded to the start of an RNA 480 bases upstream of the A6R ORF (near nucleotide 3780 in Fig. 2 The faint 220-base nuclease Si band was detected only with RNA harvested at late times (Fig. 7B) . The size of this band could correspond to an RNA starting 40 bases upstream of the ATG codon (near nucleotide 4220 in Fig. 2) . However, the 220-base band is probably an artifact resulting from RNA-RNA hybridization. A TAAAT motif is present on the complementary DNA strand, and nuclease Si analysis with an appropriate probe indicated that a strong late RNA for the A5L ORF starts there (data not shown). Hybridization of an RNA that starts upstream of the A6R ORF to the complementary A5L transcript and to the labeled single-stranded DNA probe could lead to formation of a triple complex which would produce the observed 220-base labeled band upon nuclease digestion. In agreement with such an interpretation, the amount of the 220-base band decreased when a double-stranded DNA probe was used instead of a single-stranded one (data not shown). Evidently, the unlabeled strand of probe hybridized to the A5L transcript.
Early RNA start sites, upstream of the late RNA start site of the A5L ORF and complementary to the A6R transcript, also were detected (data not shown). Formation of networks by hybridization of A5L and A6R RNAs could lead to the selection of some mRNAs encoding the rpol9 subunit by the DNA cloned in pHABam 4 (Fig. 1) .
In summary, the RNA 5'-end analysis is most compatible with the presence of an overlapping dual early/late promoter resulting in transcription initiation within the TAAATG sequence before and after DNA replication. However, additional longer RNAs also may contribute to late expression of the rpol9 gene.
Evidence for a short 5' poly(A) leader on rpol9 mRNA. The TAAATG motif, commonly found at the start of most late genes (20, 35) and some early ones (3, 22) (3, 4, 9, 16, 22, 30, 38) . Since nuclease S1 analysis localized the 5' end of the rpol9 mRNA within the TAAAT motif, we considered that this transcript might also contain a 5' poly(A) leader. Primer extension analysis of the RNA, made in the presence of cycloheximide, indicated that the 5' end of the rpol9 mRNA is heterogeneous in length, and the precise sequences could be identified only up to the ATG (Fig. 8A and C ). Since such a poly(A) leader would not be protected from nuclease S1 with a probe that is completely complementary to the genome (genomic probe; Fig. 8C ), we designed a complementary strand probe with 50 bases of poly(dT) attached to the coding region of the rpol9 gene [poly(dT)-containing probe; Fig. 8C ]. Nuclease S1 digestion of the early RNA hybridized to this poly(dT)-containing probe yielded protected bands 1 to 8 bases longer (Fig. 8B, lane 6 ) than those obtained with the genomic probe (lane 3), indicating a 4-to 11-base poly(A) leader immediately preceding the AUG codon.
Analysis of the 3' ends of the rpol9 mRNA. A singlestranded DNA probe, end labeled at nucleotide 4357 (Fig. 2) , was used to determine the 3' ends of rpol9 transcripts by nuclease S1 analysis. Discrete 3' ends were detected when early RNA was used (Fig. 9) . The ends of the early RNAs were mapped 10 to 20 bp downstream of the sequence TTTTTCT (at nucleotide 4980; Fig. 2 ). The sequence motif 'TTTTTrNT, in which N can be any nucleotide, was characterized as a general transcription termination signal for vaccinia virus early RNAs (44) . The locations of the 5' and 3' ends of the early transcript, 730 nucleotides apart as determined by nuclease S1 analyses, are consistent with the 750-nucleotide size of the RNA determined by Northern blotting. In contrast to the result obtained with early mRNA, no bands indicative of discrete 3' ends were detected with late RNA (Fig. 9) difficulty in studying them. This heterogeneity was also true for late rpol9 RNA, which appeared as a smear by Northern blotting and had no discrete 3' ends. In contrast, early rpol9 mRNA appeared as a distinct band on Northern blots, and the location of the 3' end, as determined by nuclease S1 analysis, was consistent with termination downstream of the T-T-T-T-TNT signal (44) . The 5' ends of the rpol9 mRNAs have a short poly(A) leader that apparently arises by RNA polymerase slippage when transcribing the complement of the TAAAT motif present at the start of some early genes (3, 22) . Thus far, no specific function has been associated with the untranslated poly(A) leader sequence.
When crude lysates of virus particles were applied to glycerol gradients, Western multisubunit RNA polymerase. Furthermore, the two subunits were present in similar amounts. We do not yet have accurate numbers for the stoichiometry of the RNA polymerase subunits, partly because of the chromatographic microheterogeniety of the enzyme. The Mr-21,000 polypeptides appeared to be the primary rpol9 gene product, since it comigrated in SDS-PAGE with the product of the A6R ORF made in E. coli and in reticulocyte lysates and is also the major labeled form present after a 30-min pulse with [35S]methionine at early and late times after infection. Western blot analysis indicates that the Mr-22,000 form appears late in infection but is always much less abundant than the Mr-21,000 form when the total cytoplasm is examined. Therefore, the substantial amounts of the Mr-22,000 form present in virions may result either from preferential packaging or from modification during or after packaging. In this regard, a protein kinase is present within the core of vaccinia virus virions (25a), and there is precedent for the phosphorylation of the 190-and 18-kDa subunits of yeast RNA polymerase II (25b) . Interestingly, the serine residue at position 78 of the rpol9 polypeptide is within an Arg-Arg-Xaa-Ser cyclic AMP-dependent protein kinase substrate recognition motif (13a) . Further studies are needed to determine the nature of the Mr-22,000 polypeptide and to ascertain whether it has a regulatory role.
The genome of vaccinia virus contains about 200 genes, and these genes are expressed in a highly programmed fashion. One might have anticipated, therefore, that the vaccinia virus RNA polymerase would have a simpler subunit composition than does eukaryotic RNA polymerases. This is not the case, however. Yeast RNA polymerase II has recently been shown to contain subunits that are expressed from 10 different genes (42) . The present study brings the number of vaccinia virus RNA polymerase genes to seven, and there are at least two more that remain to be identified. Thus, poxvirus and eukaryotic RNA polymerases are of similar complexity.
